Fusion Pharmaceuticals Inc. announced the appointment of Donald A. Bergstrom, M.D., Ph.D., as a member of the Company's Board of Directors. Dr. Bergstrom, who currently serves as executive vice president, head of research and development at Relay Therapeutics Inc., a clinical stage precision medicines company, brings to the board more than 15 years of experience in the biopharmaceutical industry. Prior to joining Relay Therapeutics in 2018, Dr. Bergstrom served as senior vice president, chief medical officer of Mersana Therapeutics.